Amit D. Munshi's most recent trade in Inhibikase Therapeutics Inc was a trade of 19,089 Common Stock done . Disclosure was reported to the exchange on Feb. 21, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inhibikase Therapeutics Inc | Amit D. Munshi | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Feb 2026 | 19,089 | 38,176 | - | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2025 | 16,502 | 16,502 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2025 | 6,177 | 6,177 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2025 | 2,021 | 4,021 (0%) | 0% | 0 | Common Stock | |
| Inhibikase Therapeutics Inc | Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 108,176 | 108,176 | - | - | Stock Option (Right to Buy) | |
| Galecto Inc | Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 720 | 720 | - | - | Stock Option (right to buy) | |
| Zura Bio Ltd (Class A) | Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 51,000 | 51,000 | - | - | Share Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 57,265 | 57,265 | - | 0 | Common Stock | |
| Inhibikase Therapeutics Inc | Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 116,585 | 116,585 | - | - | Stock Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 56,600 | 56,600 | - | - | Stock Option (Right to Buy) | |
| Zura Bio Ltd (Class A) | Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 117,000 | 117,000 | - | - | Share Option (Right to Buy) | |
| Inhibikase Therapeutics Inc | Amit D. Munshi | Director | Purchase of securities on an exchange or from another person at price $ 1.37 per share. | 21 Oct 2024 | 365,000 | 365,000 | - | 1.4 | 500,050 | Common Stock |
| Inhibikase Therapeutics Inc | Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Galecto Inc | Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Zura Bio Ltd (Class A) | Amit D. Munshi | Director | Purchase of securities on an exchange or from another person at price $ 3.13 per share. | 22 Apr 2024 | 159,744 | 777,384 | - | 3.1 | 499,999 | Class A ordinary shares |
| Zura Bio Ltd (Class A) | Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 3.13 per share. | 22 Apr 2024 | 159,744 | 777,384 | - | 3.1 | 499,999 | Class A ordinary shares |
| Galecto Inc | Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Zura Bio Ltd (Class A) | Amit D. Munshi | Director | Purchase of securities on an exchange or from another person at price $ 4.25 per share. | 05 Jun 2023 | 117,647 | 617,640 | - | 4.3 | 500,000 | Class A Ordinary Shares |
| Zura Bio Ltd (Class A) | Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 1,130,000 | 1,130,000 | - | - | Employee Share Option (Right to Buy) | |
| Galecto Inc | Amit D. Munshi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 18,000 | 18,000 | - | - | Stock Option (right to buy) |